Windlas Biotech Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹238.50 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.32 per cent from ₹233.10 crore. This corresponds to a year-on-year *(YoY) growth of 17.66 per cent.
Operating Profit
Operating Profit stands at ₹25.29 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.78 per cent from ₹24.37 crore. This corresponds to a year-on-year *(YoY) decline of 1.02 per cent.
PBDT
PBDT stands at ₹28.17 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.81 per cent from ₹27.67 crore. This corresponds to a year-on-year *(YoY) decline of 3.43 per cent.
Profit Before Tax
Profit Before Tax stands at ₹20.17 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.00 per cent from ₹19.97 crore. This corresponds to a year-on-year *(YoY) decline of 3.17 per cent.
Net Profit
Net Profit stands at ₹15.99 crore, reflecting a quarter-on-quarter *(QoQ) increase of 6.60 per cent from ₹15.00 crore. This represents a 1.78 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Windlas Biotech Ltd Earnings
- YOY
- QOQ
Windlas Biotech Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Windlas Biotech Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Windlas Biotech Ltd Financial Reports
Windlas Biotech Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Windlas Biotech | 0.56% | -3.39% | 1.34% | 2.08% | 7.40% | -8.76% |
| Ind-Swift Labs. | 4.54% | 11.14% | 52.33% | 76.88% | 141.00% | 131.36% |
| NGL Fine Chem | 0.01% | -1.33% | 2.49% | 42.25% | 120.27% | 143.82% |
| Hester Bios | 0.69% | -2.48% | 1.93% | 45.43% | 39.88% | 13.88% |
| Titan Biotech | 2.62% | -1.86% | -10.56% | -2.21% | 89.46% | 332.29% |
| Amrutanjan Healt | 1.07% | 1.80% | -2.32% | 2.98% | -11.56% | -24.66% |
| Jagsonpal Pharma | 1.43% | -1.52% | 9.56% | 19.67% | 28.22% | -7.95% |
Company Info
Company Information
Chairman & Independent Directo : Vivek Dhariwal
WTD & Executive Director : ASHOK KUMAR WINDLASS
Joint MD & Executive Director : MANOJ KUMAR WINDLASS
Executive Director & MD : HITESH WINDLASS
Independent Non Exe. Director : Gaurav Gulati
Non Executive Director : Prachi Jain Windlass
Executive Director : Pawan Kumar Sharma
Independent Non Exe. Director : Tarashree Singhal
Company Sec. & Compli. Officer : Ananta Narayan Panda